These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 27837233)

  • 1. Critically ill patients demonstrate large interpersonal variation in intestinal microbiota dysregulation: a pilot study.
    Lankelma JM; van Vught LA; Belzer C; Schultz MJ; van der Poll T; de Vos WM; Wiersinga WJ
    Intensive Care Med; 2017 Jan; 43(1):59-68. PubMed ID: 27837233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative gut microbiota and resistome profiling of intensive care patients receiving selective digestive tract decontamination and healthy subjects.
    Buelow E; Bello González TDJ; Fuentes S; de Steenhuijsen Piters WAA; Lahti L; Bayjanov JR; Majoor EAM; Braat JC; van Mourik MSM; Oostdijk EAN; Willems RJL; Bonten MJM; van Passel MWJ; Smidt H; van Schaik W
    Microbiome; 2017 Aug; 5(1):88. PubMed ID: 28803549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Marked Changes in Gut Microbiota in Cardio-Surgical Intensive Care Patients: A Longitudinal Cohort Study.
    Aardema H; Lisotto P; Kurilshikov A; Diepeveen JRJ; Friedrich AW; Sinha B; de Smet AMGA; Harmsen HJM
    Front Cell Infect Microbiol; 2019; 9():467. PubMed ID: 32010644
    [No Abstract]   [Full Text] [Related]  

  • 4. An in vitro study to assess the impact of tetracycline on the human intestinal microbiome.
    Jung JY; Ahn Y; Khare S; Gokulan K; Piñeiro SA; Cerniglia CE
    Anaerobe; 2018 Feb; 49():85-94. PubMed ID: 29294359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and fecal profiles of aromatic microbial metabolites reflect gut microbiota disruption in critically ill patients: a prospective observational pilot study.
    Chernevskaya E; Beloborodova N; Klimenko N; Pautova A; Shilkin D; Gusarov V; Tyakht A
    Crit Care; 2020 Jun; 24(1):312. PubMed ID: 32513224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dysbiosis of the intestinal microbiota in neurocritically ill patients and the risk for death.
    Xu R; Tan C; Zhu J; Zeng X; Gao X; Wu Q; Chen Q; Wang H; Zhou H; He Y; Pan S; Yin J
    Crit Care; 2019 May; 23(1):195. PubMed ID: 31151471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut microbiota alterations in critically ill older patients: a multicenter study.
    Victoria M; Elena VB; Amparo GN; María JA; Adriana GV; Irene AC; Alejandra YM; Janeth BB; María AG
    BMC Geriatr; 2022 Apr; 22(1):373. PubMed ID: 35484500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The altered gut microbiota in adults with cystic fibrosis.
    Burke DG; Fouhy F; Harrison MJ; Rea MC; Cotter PD; O'Sullivan O; Stanton C; Hill C; Shanahan F; Plant BJ; Ross RP
    BMC Microbiol; 2017 Mar; 17(1):58. PubMed ID: 28279152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Compartment Profiling of Bacterial and Host Metabolites Identifies Intestinal Dysbiosis and Its Functional Consequences in the Critically Ill Child.
    Wijeyesekera A; Wagner J; De Goffau M; Thurston S; Rodrigues Sabino A; Zaher S; White D; Ridout J; Peters MJ; Ramnarayan P; Branco RG; Torok ME; Valla F; Meyer R; Klein N; Frost G; Parkhill J; Holmes E; Pathan N
    Crit Care Med; 2019 Sep; 47(9):e727-e734. PubMed ID: 31169619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The nasal microbiota is a potential diagnostic biomarker for sepsis in critical care units.
    Tan X; Liu H; Qiu W; Li Z; Ge S; Luo Y; Zeng N; Chen M; Zhou Q; Cai S; Long J; Cen Z; Su J; Zhou H; He X
    Microbiol Spectr; 2024 Jul; 12(7):e0344123. PubMed ID: 38864649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota profiles in critically ill patients, potential biomarkers and risk variables for sepsis.
    Agudelo-Ochoa GM; Valdés-Duque BE; Giraldo-Giraldo NA; Jaillier-Ramírez AM; Giraldo-Villa A; Acevedo-Castaño I; Yepes-Molina MA; Barbosa-Barbosa J; Benítez-Paéz A
    Gut Microbes; 2020 Nov; 12(1):1707610. PubMed ID: 31924126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiota disruption in critically ill patients : Discussion on "Critically ill patients demonstrate large interpersonal variation of intestinal microbiota dysregulation: a pilot study".
    Iapichino G; Lankelma JM; Joost Wiersinga W
    Intensive Care Med; 2017 May; 43(5):718-719. PubMed ID: 28233052
    [No Abstract]   [Full Text] [Related]  

  • 13. Metagenomic Analysis Reveals Dynamic Changes of Whole Gut Microbiota in the Acute Phase of Intensive Care Unit Patients.
    Ojima M; Motooka D; Shimizu K; Gotoh K; Shintani A; Yoshiya K; Nakamura S; Ogura H; Iida T; Shimazu T
    Dig Dis Sci; 2016 Jun; 61(6):1628-34. PubMed ID: 26715502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Membership and behavior of ultra-low-diversity pathogen communities present in the gut of humans during prolonged critical illness.
    Zaborin A; Smith D; Garfield K; Quensen J; Shakhsheer B; Kade M; Tirrell M; Tiedje J; Gilbert JA; Zaborina O; Alverdy JC
    mBio; 2014 Sep; 5(5):e01361-14. PubMed ID: 25249279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Microbiome and Metabolome of the Gut of Children with Sepsis and Septic Shock.
    Sankar J; Thakral V; Bharadwaj K; Agarwal S; Kabra SK; Lodha R; Rathore S
    J Intensive Care Med; 2024 Jun; 39(6):514-524. PubMed ID: 38073164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibiotic-induced gut microbiota disruption during human endotoxemia: a randomised controlled study.
    Lankelma JM; Cranendonk DR; Belzer C; de Vos AF; de Vos WM; van der Poll T; Wiersinga WJ
    Gut; 2017 Sep; 66(9):1623-1630. PubMed ID: 27307305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence and Sexual Dimorphism of Gut Dysbiosis and Pathobiome after Sepsis and Trauma.
    Munley JA; Park G; Kelly LS; Kannan KB; Mankowski RT; Casadesus G; Chakrabarty P; Wallet SM; Maile R; Bible LE; Wang B; Moldawer LL; Mohr AM; Nagpal R; Efron PA
    Ann Surg; 2024 Sep; 280(3):491-503. PubMed ID: 38864230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing the fecal microbiota of infants with botulism.
    Shirey TB; Dykes JK; Lúquez C; Maslanka SE; Raphael BH
    Microbiome; 2015 Nov; 3():54. PubMed ID: 26593441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of microbial diversity and pathogen domination of the gut microbiota in critically ill patients.
    Ravi A; Halstead FD; Bamford A; Casey A; Thomson NM; van Schaik W; Snelson C; Goulden R; Foster-Nyarko E; Savva GM; Whitehouse T; Pallen MJ; Oppenheim BA
    Microb Genom; 2019 Sep; 5(9):. PubMed ID: 31526447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study.
    Shi TT; Xin Z; Hua L; Zhao RX; Yang YL; Wang H; Zhang S; Liu W; Xie RR
    J Endocrinol Invest; 2019 Aug; 42(8):967-978. PubMed ID: 30674011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.